BCRX
Biocryst Pharmaceuticals Inc
$8.37
-4.23% ($0.37)
Volume
4.04M
52W High
$11.31
52W Low
$6.00
Market Cap
$2.29B
Next Earnings Report
Last Reported
May 6, 2026 Beat
Actual: $0.14
vs. Consensus: $0.11
Price Chart
EPS History: Consensus vs Actual
Last 10 quartersPrice Movement Around Earnings
Q1 2026
May 6, 2026
1-Day:
+0.79%
5-Day:
-2.83%
Q1 2026
May 4, 2026
1-Day:
-1.85%
Q1 2026
Mar 31, 2026
1-Day:
-1.47%
Q4 2025
Feb 26, 2026
1-Day:
+10.76%
5-Day:
+10.00%
Revenue & Financial Performance
| Quarter | Revenue | YoY Growth | Gross Margin | Op Margin | Net Income |
|---|---|---|---|---|---|
| Q4'25 | $406.6M | +209.1% | 97.6% | 64.1% | $245.8M |
| Q3'25 | $159.4M | +36.1% | 98.4% | 18.6% | $12.9M |
| Q2'25 | $163.4M | +49.4% | 98.3% | 18.2% | $5.1M |
| Q1'25 | $145.5M | +56.9% | 96.9% | 14.6% | $32,000 |
| Q4'24 | $131.5M | +40.8% | 95.3% | -3.4% | -$26.8M |
| Q3'24 | $117.1M | +35.0% | 97.2% | 6.6% | -$14.0M |
| Q2'24 | $109.3M | +32.5% | 98.5% | 8.0% | -$12.7M |
| Q1'24 | $92.8M | +34.9% | 98.6% | -15.6% | -$35.4M |
Company Information
Symbol
BCRX
Company
Biocryst Pharmaceuticals Inc
Market Cap
$2.29B